, Volume 7, Issue 4, pp 214-216
Date: 15 Jun 2006

Spontaneous splenic infarction associated with sumatriptan use

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Triptans are specific agonists of the serotonergic 5-HT1B/1D receptors that have increasingly been used in the treatment of migraine and cluster headaches. Though they are generally considered safe, there have been a few reports of myocardial infarction and stroke associated with triptan use. We report a patient who developed spontaneous splenic infarction after the use of sumatriptan for the treatment of migraine headache.